A detailed history of Net Worth Advisory Group transactions in Novo Nordisk A S stock. As of the latest transaction made, Net Worth Advisory Group holds 6,257 shares of NVO stock, worth $303,214. This represents 0.1% of its overall portfolio holdings.

Number of Shares
6,257
Previous 7,385 15.27%
Holding current value
$303,214
Previous $510 Million 31.88%
% of portfolio
0.1%
Previous 0.11%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 14, 2025

SELL
$45.38 - $71.7 $51,188 - $80,877
-1,128 Reduced 15.27%
6,257 $347 Million
Q2 2025

Jul 21, 2025

BUY
$58.08 - $81.05 $93,218 - $130,085
1,605 Added 27.77%
7,385 $510 Million
Q1 2025

Apr 15, 2025

SELL
$69.3 - $90.95 $2,148 - $2,819
-31 Reduced 0.53%
5,780 $401 Million
Q4 2024

Feb 07, 2025

SELL
$85.0 - $120.04 $20,655 - $29,169
-243 Reduced 4.01%
5,811 $500 Million
Q3 2024

Oct 17, 2024

BUY
$119.07 - $145.42 $720,849 - $880,372
6,054 New
6,054 $721 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $109B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Net Worth Advisory Group Portfolio

Follow Net Worth Advisory Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Net Worth Advisory Group, based on Form 13F filings with the SEC.

News

Stay updated on Net Worth Advisory Group with notifications on news.